Recall of Popular Over-the-Counter Drugs by Johnson and Johnson

by Editor

Johnson and Johnson recall TYLENOL

Johnson and Johnson recall TYLENOL

McNeil Consumer Healthcare has recalled millions of bottles and packages of popular over-the-counter (OTC) drugs, according to their website.

"McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc. is voluntarily recalling, at the wholesale level, certain lots of TYLENOL 8 Hour, TYLENOL Arthritis Pain, and TYLENOL upper respiratory products, and certain lots of BENADRYL, SUDAFED PE, and SINUTAB products distributed in the United States, the Caribbean, and Brazil," the company reported in information published on their website on January 14, 2011.

The products included in the recall, referred to as a precautionary measure, were manufactured in the company's Fort Washington, Pennsylvania plant, before production was supsended there due to inadequate equipment cleaning procedures.

The recalls are at the wholesale level. The company is also recalling some tablets from their ROLAIDS line for other reasons, they said.

Although the company maintains that "no action is required by consumers or healthcare providers and consumers can continue to use the product. These actions are not being undertaken on the basis of adverse events," Natural Helath Strategies suggests precaution on an individual level. Given the track record of the pharmaceutical industry and the FDA (remember VIOXX? And that just one of many tragic examples), I personally would not hesitate to stop taking these products, if I were a user of them, which I am not.

Many other products from the same company, including Motrin, have also been recalled within the past 12 months alone. You can find out more information about the company's recalled drugs on McNeil's website.

Related News: Johnson & Johnson Sued by State of Oregon For Selling Defective Motrin

The state of Oregon filed a lawsuit on January 12, 2011, against Johnson & Johnson and its division McNeil Consumer Healthcare, alleging that the company "exposed comsumers to defective supplies of Motrin" because they knew of the problem for over a year before publicly recalling it in 2010.

According to allegations in the state's lawsuit, instead of conducting an immediate public recall (as would have been the correct course of action),
J & J and its subsidiaries surreptitiously removed Motrin from stores where it was sold by hiring contractors in early 2009 to buy up the defective Motrin products without notifying the public, retailers, or wholesalers--a "phantom recall".

In July, 2009, one of those hired to quietly buy up the defective product in Oregon informed that state's Board of Pharmacy, which then notified the FDA. We can be thankful that this person's concern for the public caused him to act!

The company's unstraightforward way of handling the defective Motrin product endangered both people who had already purchased the product and many more consumers who continued to unknowingly buy and use a defective product for more than a year before the company admitted the problem publicly.

Source: Philadelphia Business Journal


Comments for Recall of Popular Over-the-Counter Drugs by Johnson and Johnson

Click here to add your own comments

Jan 19, 2011
J&J Recalls Rolaids
by: Natural Health Ed

The Wall Street Journal also ran several articles about the recalls. Here are excerpts from some of them:

J&J has issued a series of recalls of medicines including Tylenol, Benadryl and Motrin, for various quality lapses such as excessive concentrations of active ingredients and musty odors. J&J's handling of the recalls has sparked investigations by government entities, including a criminal probe by the Justice Department.

The House Committee on Oversight and Government Reform also has probed the recalls. The incoming chairman, Rep. Darrell Issa (R., Calif.) issued a statement Thursday saying the "most recent recall reinforces the Committee's ongoing investigation surrounding the safety protocols in place at J&J's facilities and how the [Food and Drug Administration] is managing food and drug safety." The committee will continue to seek answers from J&J and the FDA, the statement said.

Earlier Thursday, Wells Fargo downgraded its rating for J&J shares, citing the potential for further regulatory action on J&J that could shut down a manufacturing plant in Puerto Rico where quality problems have been detected.

Read more the full article here.

Click here to add your own comments

Return to Natural Health in the News.

Read in Your Language!




Please support our sponsors:

Radiation Protection
Recommended
Products

Moxxor Mercury-free

Read in Your Language!


Please support our sponsors:

Radiation Protection
Recommended
Products

Moxxor Mercury-free
iHerb - The Best Overall Source for Natural Products